H.C. Wainwright Maintains Buy Rating on Allogene Therapeutics (ALLO)
Summary
On April 15, 2026, H.C. Wainwright lowered its price target on Allogene Therapeutics, Inc.
Description
On April 15, 2026, H.C. Wainwright lowered its price target on Allogene Therapeutics, Inc.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source